MedPath

A comparative study to show the efficacy of Triphadi ghrita and Albendazole in the management of intestinal worms in children.

Phase 2
Conditions
Health Condition 1: B80- Enterobiasis
Registration Number
CTRI/2024/07/070861
Lead Sponsor
Dr Puja Kumari
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients with sign and symptoms of krimi roga.

Age 3 to 12 years.

Exclusion Criteria

Patients not willing for trial.

Patients affected with any systemic disease.

Patients on any other medication.

Age more than 12 years and less than 3 years.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath